Last year, from my parents’ windows in Penang, Malaysia, a dark arm of sand appeared on the surface of the water. It was ...
TipRanks on MSN
Amgen, AstraZeneca announce FDA approval of Tezspire
Amgen (AMGN) and AstraZeneca (AZN) announced that the U.S. FDA approved Tezspire for the add-on maintenance treatment of inadequately controlled ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback